Giovanni Lucignani

CARICAMENTO...

Giovanella L, Castellani M, Suriano S, Ruberto T, Ceriani L, Tagliabue L, Lucignani G.

Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer.

Tumori. 2011 Sep-Oct;97(5):629-33.

Martelli C, Borelli M, Ottobrini L, Rainone V, Degrassi A, Russo M, Gianelli U, Bosari S, Fiorini C, Trabattoni D, Clerici M, Lucignani G.

In Vivo Imaging of Lymph Node Migration of MNP- and (111)In-Labeled Dendritic Cells in a Transgenic Mouse Model of Breast Cancer (MMTV-Ras)

Mol Imaging Biol. 2011 May 21

Libani IV, Lucignani G, Gianelli U, Degrassi A, Russo M, Bosari S, Clerici M, Ottobrini L.

Labeling Protocols for In Vivo Tracking of Human Skeletal Muscle Cells (HSkMCs) by Magnetic Resonance and Bioluminescence Imaging.

Mol Imaging Biol. 2012 Feb;14(1):47-59.

Lucignani G, Rodriguez-Porcel M.

In vivo imaging for stem cell therapy: new developments and future challenges.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):400-5.

Lucignani G.

Čerenkov radioactive optical imaging: a promising new strategy.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):592-5.

Ottobrini L, Martelli C, Trabattoni DL, Clerici M, Lucignani G.

In vivo imaging of immune cell trafficking in cancer.

Eur J Nucl Med Mol Imaging. 2011 May;38(5):949-68.

Lucignani G, De Palma D.

PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):179-84.

Lucignani G, Schäfers M.

PET, CT and MRI characterisation of the atherosclerotic plaque.

Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2398-402.

Lucignani G, Del Sole A.

Nuclear medicine: what kind of quality would we want if we were the patient?

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2194-8

Del Sole A, Chiesa V, Lucignani G, Vignoli A, Giordano L, Lecchi M, Canevini MP.

Exploring dopaminergic activity in ring chromosome 20 syndrome: a SPECT study.

Q J Nucl Med Mol Imaging. 2010 Oct;54(5):564-569 .

Lucignani G, Nobili F.

FDG-PET for early assessment of Alzheimer's disease: isn't the evidence base large enough?

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1604-9.

Lucignani G, Zaidi H.

PET-guided prostate cancer radiotherapy: technological innovations for dose delivery optimisation.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1426-9.

Salvatori M, Lucignani G.

Radiation exposure, protection and risk from nuclear medicine procedures.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1225-31.

Lu F, Carlino M, Lu C, Landoni C, Lucignani G, Fragasso G, Bello VD, Margonato A, Chierchia SL, Marzilli M, Balbarini A.

Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up.

Echocardiography. 2010 May 1;27(5):544-51.

Lucignani G, Larson SM.

Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):1032-8.

Borasi G, Fioroni F, Del Guerra A, Lucignani G.

PET systems: the value of added length.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1629-32.

Bombardieri E, Coliva A, Maccauro M, Seregni E, Orunesu E, Chiti A, Lucignani G.

Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals

Q J Nucl Med Mol Imaging. 2010 Feb;54 (1):3-15.

Giovanella L, Lucignani G.

Hybrid versus fusion imaging: are we moving forward judiciously?

Eur J Nucl Med Mol Imaging. 2010 May;37(5):973-9.

Hustinx R, Lucignani G.

PET/CT in head and neck cancer: an update.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):645-51.

Lucignani G, Perneczky R.

Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):399-404.